About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Study Evaluates Prediction of Severe COVID-19 Outcome

by Angela Mohan on January 21, 2021 at 12:12 PM
Font : A-A+

Study Evaluates Prediction of Severe COVID-19 Outcome

National Early Warning Risk Score (NEWS) 2 could be used as a scoring system for predicting severe COVID-19 outcomes in patients, as per researchers at King's College London.

Researchers found poor-to-moderate accuracy for identifying patients at risk of being transferred to intensive care units (ICUs) or dying after 14 days of hospitalization.

Advertisement


Accuracy of predictions in short term (three days) showed moderate success.

For people who are hospitalized with severe COVID-19, it is vital to quickly identify which patients may deteriorate and require transfer to an intensive care unit (ICU) for organ support or may die.
Advertisement

NEWS2 is an early warning score that combines physiological parameters such as respiration rate, oxygen saturation, blood pressure and temperature.

NEWS2 is currently used almost universally in UK NHS Trusts to identify which patients are at risk of deteriorating early.

The paper was published in BMC Medicine.

Accuracy of NEWS2

Researchers analyzed data from 1,276 COVID-19 patients admitted to King's College Hospital NHS Foundation Trust during the first wave in March-April 2020.

The team then validated their models using data for over 6,000 patients across eight other hospitals globally (five in the UK, one in Norway, and two in China). At all UK sites, around one third of patients with COVID-19 were transferred to ICU or died within 14 days of hospital admission.

The researchers evaluated how well patients' NEWS2 scores measured at hospital admission anticipated who would have severe COVID-19 outcomes, which means either being transferred to ICU or dying.

In all UK sites, combining NEWS2 and age to predict outcomes showed moderate success in the short term (three days), but for poor-to-moderate success for medium-term (14 days) outcomes.

Dr Ewan Carr, Statistician Research Fellow at the Institute of Psychiatry, Psychology & Neuroscience, King's College London, and co-lead author said: "We have conducted the largest study to date evaluating the accuracy of NEWS2 for predicting medium-term COVID outcomes.

NEWS2 is widely used in UK NHS trusts but little is known about how well it can predict severe COVID outcomes and so evaluating its accuracy is important as we look to improve patient care now and in future.

By collecting data from nine hospitals globally, our results have robust external validation. We found consistency across sites both in the performance of NEWS2 alone, as well as for the supplemented model.

In short, NEWS2 tended to have poor-moderate performance but was improved by adding common blood and physiological measures."

The research team used CogStack, an existing platform developed by NIHR Maudsley BRC and in use at King's College Hospital NHS Foundation Trust, which allows for rapid extraction and processing of data from patient's electronic health records.

Professor Richard Dobson, Head of the Department of Biostatistics & Health Informatics, NIHR Maudsley BRC, said: "The CogStack platform allows us to extract information from deep within hospital records at King's College Hospital NHS Foundation Trust in real time in order really explore complex questions such as this. This includes being able to extract information relating to co-morbidities, for example, that may only be mentioned in passing in the physician narrative"

Improving predictive ability

Researchers found that accuracy in predicting severe outcomes was improved by considering routinely-collected blood and physiological parameters from patients including age, oxygen saturation and neutrophil count, which is an important infection-fighting immune system cell. In models that supplemented NEWS2 with these parameters the ability to predict severe outcomes was improved.

Dr James Teo, Consultant Neurologist at King's College Hospital and Clinical Director of Data Science and lead of CogStack platform, said: "Our results for the first time validates NEWS2, and shows how it could be improved by adding common blood and physiological parameters.

Thankfully, this NHS scoring system is easy to adapt and implement in real-world clinical practice, compared to other complex risk-scoring models.

I, alongside all the authors and collaborators, would like to thank the guidance and contributions of the patients and members of the King's Electronic Records Research Interface that made this all possible."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Monkeypox Outbreak: What it is, How Does it Spread & the Prevention
Seasonal Allergy Medications
How to Choose the Best Eczema-Friendly Moisturizer for Children?
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Coronavirus Indian Namaste the Preferred Greeting over Conventional Handshake COVID in Children COVID Vaccination for Pregnant Women COVID-19 Vaccine: Myths and Facts Mental Health during COVID-19: Top Tips to Manage COVID Anxiety, Depression How to Find Joy and Hope during COVID Times 

Most Popular on Medindia

Blood Donation - Recipients Find a Hospital How to Reduce School Bag Weight - Simple Tips Post-Nasal Drip Drug Interaction Checker Turmeric Powder - Health Benefits, Uses & Side Effects Sanatogen Drug Side Effects Calculator Blood Pressure Calculator Noscaphene (Noscapine)

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR